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Abstract: The Biocidal Products Regulation (BPR) contains several provisions for nanomaterials
(NMs) and is the first regulation in the European Union to require specific testing and risk assessment
for the NM form of a biocidal substance as a part of the information requirements. Ecotoxicological
data are one of the pillars of the information requirements in the BPR, but there are currently no
standard test guidelines for the ecotoxicity testing of NMs. The overall objective of this work
was to investigate the implications of the introduction of nano-specific testing requirements in the
BPR and to explore how these might be fulfilled in the case of copper oxide nanoparticles. While
there is information and data available in the open literature that could be used to fulfill the BPR
information requirements, most of the studies do not take the Organisation for Economic Co-operation
and Development’s nanospecific test guidelines into consideration. This makes it difficult for
companies as well as regulators to fulfill the BPR information requirements for nanomaterials.
In order to enable a nanospecific risk assessment, best practices need to be developed regarding stock
suspension preparation and characterization, exposure suspensions preparation, and for conducting
ecotoxicological test.
Keywords: biocides; nanomaterials; European Union (EU) policy; regulation; risk assessment; ecotoxicity
1. Introduction
Nanomaterials (NM) are increasingly being incorporated into consumer products such as textiles
and paints to provide a biocidal effect. Regulatory bodies in Europe have recognized that there is
a need for legislation within the field of nanotechnology, and specific provisions regarding NMs
are now being introduced into different legislations in the European Union. The Cosmetic Products
Regulation was the first European legislation to include specific provisions regarding labeling of
products containing NMs, and similar ingredient labeling provisions were later included in the EU
regulation for food information to consumers [1–3].
In 2013, the European Biocidal Product Regulation (BPR) came into force. This regulation includes
even more comprehensive provisions regarding NMs compared to the Cosmetic Products Regulation,
and is the first European regulation to include specific testing requirements of NMs as a part of the
information requirements [4]. The BPR covers not only active substances that are used to suppress the
growth of organisms, which are harmful to human or environmental health, but also biocidal products
and treated articles [5]. Biocidal products are defined as: (1) any substance or mixture consisting of,
containing or generating one or more active substances; and (2) any substance or mixture, generated
from substances or mixtures, which do not themselves fall under the former category of biocidal
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products. A treated article shall be considered a biocidal product if it has a primary biocidal function
according to the Biocide Pesticide Regulation (BPR) [4].
It is well established that nanomaterials pose unique challenges for ecotoxicological testing
using the currently available guideline tests [6–12] and is not clear exactly how manufacturers
of biocidal nanomaterials can fulfill the nanospecific requirements of the BPR due to these
methodological challenges.
In this paper, we focus on the EU regulation of nanobiocidal products, summarize the nanospecific
requirements of the Biocide Pesticide Regulation (BPR), and analyze how the BPR requirements
could be fulfilled for the case of copper oxide (CuO) nanoparticles (NPs) using the open literature.
This manuscript includes a discussion of relevant Organisation for Economic Co-operation and
Development (OECD) Guidance documents and scientific information regarding aquatic ecotoxicity
testing of metal NPs. Finally, we provide a discussion of the deficiencies of existing test guidelines
and the challenges facing manufacturers and regulators in implementing the BPR requirements
for nanomaterials.
2. The BPR and the Introduction of Nanospecific Provisions
Specific requirements regarding NMs were not included in the first draft of the legislative proposal
for a biocide regulation from the European Commission [13]. It was not until the first reading in the
European Parliament (EP) that specific provisions regarding NMs were proposed. The EP decided to
include nano-specific provisions in the BPR due to scientific uncertainty about the safety of NMs [14].
This was based on a report from the Scientific Committee on Emerging and Newly Identified Health
Risks (SCENIHR), which had identified health hazards and toxic effects of some NMs. The report
furthermore found that high-quality data on exposure of both humans and the environment were
lacking and concluded that the methods for exposure estimates and hazard identification for NMs
needed to be further developed and standardized. Based on this information, along with the fact
that the use of NMs in biocidal product may increase as the technology develops, the EP decided
to accept the BPR under the condition that a series of nano-specific provisions were introduced [14].
The Council of the European Union first suggested that the nanospecific provisions should be less
comprehensive than in the proposal from the EP, but in the end they accepted them as proposed by
the EP. This resulted in the BPR becoming the first piece of European legislation to implement the
recommended definition of NMs from the European Commission [15].
The recommended definition of NM by the European Commission states that a NM is: “A natural,
incidental or manufactured material containing particles, in an unbound state or as an aggregate or as
an agglomerate and where, for 50% or more of the particles in the number size distribution, one or
more external dimensions is in the size range 1 nm–100 nm. In specific cases and where warranted by
concerns for the environment, health, safety or competitiveness the number size distribution threshold
of 50% may be replaced by a threshold between 1% and 50%” [15].
However, only the first part of the recommended definition is adopted by the BPR and the possible
replacement of the 50% threshold by a lower one has been omitted. The incidentally created NPs are
omitted from the BPR definition of NMs as well. The definition of aggregates and agglomerates in the
BPR correspond to the recommended definitions from the European Commission [4].
Besides being the first piece of legislation to adopt the definition of NMs recommended by the
European Commission, the BPR is also the first to specify that an approval of an active substance does
not cover a corresponding NM form, except when this is it explicitly mentioned [4]. The reasoning for
this provision is that NMs will be used as a biocide because of their different properties compared to
the bulk form of the substance. These different properties may also result in different toxicities, and
therefore NMs require a separate assessment. This means that in order to obtain an authorization of
a biocidal product that contains NMs, a specific risk assessment has to be performed for the NM in
question and documentation has to be provided to justify that the test performed are relevant and
applicable for NMs [4]. Furthermore, the BPR makes it clear that it is not possible to apply for a
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simplified authorization, which is due to the current lack of adequate risk assessment methods when it
comes to biocidal product that contain NMs [4,14].
The BPR further contains requirements regarding labeling of biocidal products and treated articles.
In addition to other information, all biocidal products containing NMs must have a label, stating the
NMs contained in the product, including information on any specific related risks of the NMs and
the word “nano” in brackets following each reference to the given NM [4]. For articles treated with a
biocidal product containing NMs, labeling with information of the names of all NMs contained in the
product, followed by the word “nano” in brackets, is required [4]. The specific labeling provisions for
these materials were included by the EP in recognition of the users’ rights to be informed via adequate
labeling given the lack of knowledge on health and environmental impact of NMs [14].
Once a biocidal product is introduced onto the market, each Member State is obliged to submit a
report to the European Commission every five years including details of the use of NMs in biocidal
products and the potential risk hereof [4].
3. Information Requirements for Nanospecific Test Results and Testing Methods
In order to obtain an approval of an active substance and/or a biocidal product, a dossier must be
submitted to the competent authority in a chosen member state in the EU. For the active substance, the
dossier must fulfill specific information requirements, outlined in Annex II of the BPR, whereas the
biocidal product must fulfill the information requirements set out in Annex III [4].
The data requirements, as specified in Annex II and III, comprise a Core Data Set (CDS) and
an Additional Data Set (ADS). The CDS is the basis data that, in principle, must be provided for all
active substances. There may, however, be cases where it is not possible to generate all data elements
belonging to the CDS. This applies in special cases, where physical or chemical properties render it
impossible or unnecessary to provide certain data. The ADS to be provided is determined by the
physio-chemical properties of the chemical in question, for which type of products the active substance
is used, and the exposure patterns that are related to that use (see paragraph 2 in Annex II and Annex III
of [4]). For each endpoint in the CDS, at least one key study (or an accepted data waiving justification)
must be submitted and the study has to be reliable and adequate to use for the risk assessment [16].
According to Annex II [5] of the BPR the data submitted to support the approval of an active substance
must be obtained according to the methods specified in the Test Methods Regulation [17]. For most
CDS, the relevant test methods described in the Test Methods Regulation are equivalent to OECD
guidelines (see Table 1). If a test method is considered inadequate or not included in this regulation, it
is possible to use other scientifically suitable methods; however, justification for the appropriateness
of these alternative methods is required. For testing of NMs it is stated that “when test methods
are applied to nanomaterials, an explanation shall be provided of their scientific appropriateness for
NMs, and where applicable, of the technical adaptations/adjustments that have been made in order to
respond to the specific characteristics of these materials” (see paragraph 5 of Annex II and Annex III
of [4]).
Nanomaterials 2016, 6, 33 4 of 16
Table 1. Information requirements according to Annex II of the Biocidal Product Regulation for
ecotoxicity testing, including corresponding test methods as set out in Regulation EC 440/2008
(CDS = Core Data Set, ADS = Additional Data Set, TG = Test Guideline). Data from [4,17].
Test Specification Data set Test method according to regulationEC 440/2008 [17]
Toxicity to Aquatic Organisms
Short-term toxicity testing on fish CDS * Test method C1
Short-term toxicity testing on
aquatic invertebrates Test species: Daphnia magna CDS Equivalent to OECD TG 202 (2004)
Other species ADS
Growth inhibition study on algae Effects on growth rate of green algae CDS Equivalent to OECD TG 201 (2006) **
Effects on growth rate of
cyanobacteria or diatoms CDS Equivalent to OECD TG 201 (2006) **
Bioconcentration Estimation methodsExperimental determination CDS *** Equivalent to OECD TG 305 (1996)
Inhibition of microbial activity CDS Method C.11.
Further Toxicity Studies on Aquatic Organisms ****
Long term toxicity tests on Fish
Fish Early Life Stage (FELS) test;
Fish short term toxicity test in embryo
and sack fry stages
Fish juvenile growth test
Fish full life circle test
ADS (b) Equivalent to OECD 212 (1998)(c) Equivalent to OECD TG 215 (2000)
Long term toxicity testing on
invertebrate
Daphnia growth and
reproductive study
Other species reproduction and
growth (e.g., Mysid)
Other species development and
emergence (e.g., Chironomus)
ADS (a) Equivalent to OECD TG 211 (1998)
Bioaccumulation in any appropriate
aquatic species ADS
Effects on any other specific,
non-target organisms
Non-target organisms: flora and
fauna believed to be at risk ADS
Studies on
sediment-dwelling organisms ADS
Effects on aquatic macrophytes ADS
Notes: * Data element not required if a valid long-term study on fish is available. ** From EC 761/2009 amending
EC 440/2008 [17]. *** Data element not required if it can be demonstrated (on the basis of physical-chemical
properties (e.g., logKow < 3) or other) that the substance has low bioaccumulation potential. **** If the results
from the ecotoxicity studies on fate and behavior and/or the intended use(s) of the active substance indicate a
risk for the aquatic environment, or if long term exposure is expected, then one or more of the tests mentioned
as ADS in the table must be conducted [4].
4. OECD and Ecotoxicological Testing of Nanomaterials
The BPR requires nano-specific tests or argumentation for the appropriateness of existing test
methods, and specific risk assessment of NMs in order to authorize active substances and/or biocidal
products [4]. As mentioned in the introduction, there are currently no actual OECD test guidelines
for ecotoxicity testing of NMs [18]. However, to address the challenges of testing NMs the OECD has
established the Working Party on Manufactured NMs (WPNM) in 2006, and its subsequent activities
(e.g., OECD’s Sponsorship Programme on the Testing on Manufactured NMs) [19].
In 2009, a preliminary review of the current OECD test guidelines for their applicability to NMs
was published by the OECD WPNM. For ecotoxicity testing, 24 test guidelines were reviewed with the
aim to assess their adequacy in addressing NMs, and in order to identify the need for development of
new test guidelines or a revision of the existing test guidelines [20].
The key findings of the review was that all test guidelines contained insufficient guidance for
testing of NMs with regards to:
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‚ Material characterization;
‚ Exposure preparation and delivery of substance to test systems;
‚ Monitoring of stability and consistency of NMs during the tests; and
‚ Measurement and use of dose metrics.
It was, however, found that the basic toxicological principles and the test endpoints were adequate
for the testing of NMs. The recommendation was therefore not to launch an extensive modification of
all OECD guidelines, but rather to address the specific issues related to testing of NMs in a separate
document. This work is currently ongoing and the process of drafting this guidance document on
aquatic testing of NMs is described elsewhere [12]. It was also highlighted that the terminology used
in the existing guidelines in many cases was not applicable for NMs, and that these terms needed to be
revised as well [19]. As the preliminary review revealed, one of the primary shortages of the current
test guidelines was guidance on sample preparation. As a result of this, OECD published the Guidance
Document on Sample Preparation and Dosimetry in 2010, and this was reviewed and amended
in 2012 [18]. The guidance outlines important considerations to bear in mind in order to obtain
meaningful and reproducible test results [18]. Regarding preparation of samples of NMs for ecotoxicity
studies, the guidance document states that the following issues should be taken into consideration:
methods of suspension, quantification of media quality and physical-chemical characterization of
the NM. Table 2 gives an overview of the most important points and possible suggestions for the
preparations of NM samples in aquatic media according to the OECD guidance document [18].
Table 2. Overview of issues and considerations regarding preparation of samples of NMs in exposure
media for aquatic ecotoxicity studies. Data from [18].
Issues Considerations Recommendations
Method of suspension (e.g., stirring,
sonication, grinding, use of solvents
and stabilizing agents)
Different suspension methods may
significantly alter the NMs per se or the
toxic properties of the NM.
Best scientific judgment should be used.
If there is evidence of altered toxicity, the
effects should be controlled or quantified.
Quantification of media quality (e.g.,
pH, ionic strength and concentration
of dissolved organic matter)
Variability in NM properties (e.g.,
agglomeration/aggregation) depend
significantly on media pH, ionic
strength and concentration and form of
dissolved organic matter.
Media quality determination should be
made at intervals sufficient to determine
their variability (both in stock suspension
and test media); Physical-chemical
characterization of NM should be made in
the actual test media (whenever possible).
Physical-chemical characterization
Agglomeration/aggregation is likely to
occur, which may alter the exposure due
to reduced particle counts, surface area
or loss of bulk concentration.
Particle size and/or agglomerate size
distribution and material concentration
must be assessed at intervals during the
tests (or at a minimum immediately prior to
and after media renewal).
Measurements of particle size distribution
using two or more methods are desirable.
Characterization should be made in the test
media in the presence of test organisms
(and food if feeding is required).
In January 2013, an expert meeting on ecotoxicology and environmental fate of NMs took place in
Berlin as a part of the OECD program on the safety of manufactured NMs. The objective of the meeting
was to discuss the applicability of the current OECD test guidelines to NMs and provide specific
guidance on environmental fate and ecotoxicity testing of these materials. The Guidance Document on
Sample Preparation and Dosimetry [18] and the Preliminary review of the OECD Test Guidelines [20]
should subsequently be updated based on the recommendations made at the expert meeting, but this
update has yet to take place. The conclusions and recommendations from the OECD expert meeting
are available from the OECD website [21] and have been published in the scientific literature [22]. It is
clear that current OECD Tech Guidelines for ecotoxicity testing, although principally applicable to
NMs, are lacking specific guidance on NM specific testing issues, as also recently highlighted in the
scientific literature [12]. Additional NM specific guidance will hopefully become available within the
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foreseeable future as a result of ongoing activities within the OECD. Until then, appropriate testing of
NMs is largely based on what can be learned from the open scientific literature, which is the basis of
this present analysis.
5. Fulfilling the Requirements of the BPR for Copper Oxide
Up to this point, we have discussed the BPR, its requirements, and the OECD evaluation of the
applicability of current test guidelines for nanoparticles. In this section, we provide an illustration of
how the requirements of the BPR can be implemented for copper oxide nanoparticles (CuNPs).
While silver is the most commonly used biocidal NM [23,24] other metal nanoparticles (NPs)
are also being used in products for a biocidal effect [25,26]. Silver, TiO2 and ZnO nanoparticles have
been studied and characterized to a greater extent than CuO NPs [23,27]. CuO NPs are used as
biocides in a range of different products, such as textiles, plastics and paints [28–30] and the use
of CuO NPs is increasing [31]. The increasing use of NPs for different industrial and commercial
applications will inevitably lead to an increased release to the environment [27,32] and once released,
aquatic ecosystems are likely to become the receiving bodies for these NMs [32,33]. The actual
occurrences and concentrations of CuO NPs in the aquatic environment are, however, unknown due
to lack of sufficiently sensitive analytical quantification methods [30]. Various studies of CuO NPs
have reported toxicity of CuO NPs towards aquatic organisms such as algae [34], bacteria [26,35],
crustaceans [26,35,36], protozoa [37], plants [30], and fish [38] (See Table 3).
When it comes to providing data to fulfill the different information requirements in the BPR
regarding ecotoxicological effects the number of studies vary to a great extent between different
organism groups (see Figure 1). For instance, the data contained in the 15 studies available on
“Short-term toxicity testing on aquatic invertebrates” are likely to fulfill the BPR requirement, whereas
very few data are available on “bioaccumulation in any appropriate aquatic species”. Eight studies
are available on growth inhibition on algae and on inhibition of microbial activity, whereas six are
available for short term toxicity towards fish. In regard to assessing the long term toxicity of CuO NP,
only one study is available on the long term toxicity on invertebrates, whereas four to six studies are
available on the other information requirements except for effects on aquatic macrophytes for which
no study is available.
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Figure 1. Number of studies potentially fulfilling the Biocidal Product Regulation (BPR) information
requirements for ecotoxicity tests.
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Table 3. Overview of studies published in the open literature on CuO Nanoparticles (NPs) and their relation to the information requirement of the Biocidal Product
Regulation (BPR). Furthermore, it is shown which test guidelines the studies have used and which of the nanospecific Organisation for Economic Co-operation and
Development (OECD) test and characterization recommendations [18] have been followed.
Reference [39] [32] [26] [34] [33] [40] [41] [42] [43] [37] [44] [45] [31] [46] [47] [48] [49] [38] [50] [51] [52] [36] [53] [54] [55] [56] [57] [58] [59] [60] [61]
Information requirement in accordance with BPR
Short-term toxicity test on fish x x x x
Short term toxicity testing on aquatic invertebrates x x x x x x x x x x x x
Growth inhibition study on algae x x x x x x x
Bioconcentration
Inhibition of microbial activity x x x x
Long term toxicity tests on Fish x x
Long term toxicity testing on invertebrate
Bioaccumulation in any appropriate aquatic species x x
Effects on any other specific, non-target organisms x x x
Studies on sediment-dwelling organisms x x
Effects on aquatic macrophytes
Test Guideline followed a b c c a a d c d
OECD ENV/JM/MONO (2012) 40 recommendations
Method of suspension x x x x x x x x x x x x x x x x x x x x x x x x x x
Suspension media x x x x x x x x x x x x x x x x x x x x x x x x x x x
Quantification/control of potentially altered toxicity? x x x
pH x x x x x x x x x x x x x x x x x x
Dissolved organic matter x x x x x x
Ionic strength x x x x x x x
Determinations made at intervals in the stock solution x x x
Determinations made at intervals in the test media x x x x x
Characterization made of (dry) particles x x x x x x x x x x x x x x
Characterization made in actual test media x x x x x x x x x x x x x x
Characterization made in stock solution x x x x x x x x x x x x x
Characterization made in presence of test organisms? x x x x
Particle/agglomeration size distribution and material
concentration assessed at intervals? x x x x x x x x x x
Particle/aggregate/agglomeration size distribution
measured using two or more methods? [method(s)] x x x x x x x x x x x x x x x
Degradation of nanomaterial investigated?
(release of Cu+ ions) x x x x x x x x x x x x x x x x x x x x
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Table 3. Cont.
Reference [62] [63] [64] [65] [66] [67] [30] [68] [35] [69] [70] [71] [72] [73] [74]
Information requirement in accordance with BPR
Short-term toxicity test on fish x
Short term toxicity testing on aquatic invertebrates x x x
Growth inhibition study on algae x
Bioconcentration
Inhibition of microbial activity x x x x
Long term toxicity tests on Fish x x x x
Long term toxicity testing on invertebrate x
Bioaccumulation in any appropriate aquatic species x
Effects on any other specific, non-target organisms x
Studies on sediment-dwelling organisms x x x
Effects on aquatic macrophytes
Test Guideline followed e a f, g, h, i f j
OECD ENV/JM/MONO (2012) 40 recommendations
Method of suspension x x x x x x x x x x
Suspension media x x x x x x x x x x
Quantification/control of potentially altered toxicity?
pH x x x x x x x x x
Dissolved organic matter x x x x
Ionic strength x x x x x
Determinations made at intervals in the stock solution
Determinations made at intervals in the test media x
Characterization made of (dry) particles x x x x x x x
Characterization made in actual test media x x x x x x x
Characterization made in stock solution x x x x x
Characterization made in presence of test organisms?
Particle/agglomeration size distribution and material
concentration assessed at intervals? x x x
Particle/aggregate/agglomeration size distribution
measured using two or more methods? [method(s)] x x x x
Notes: (a) ASTM; (b) OECD 201; (c) OECD 202; (d) U.S. EPA; (e) OECD 203/210; (f) ISO6341; (g) ISO 10706; (h) ISO 11348-3; (i) NBR 15411-3; (j) OECD 221.
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When it comes to following the OECD recommendations for characterization and reporting of the
15 different nanospecific parameters shown in Table 3, the studies vary to a great extent. The studies
that report most of the parameters, report on seven to nine of these. However about a third of all the
studies report on four or less of the parameters suggested by the OECD. The parameters most often
reported on are the method of suspension and the suspension media, which is reported in almost
three-quarters of all the studies (see Figure 2). pH and the release of copper ions is reported in the
a little more than half of the studies. Characterization of (dry) particles, in the actual test media and
in the stock suspension is reported in about one third of all the studies. However, only five studies
seemingly characterize the tested NPs in their dry form, in the test media as well as in the stock solution.
About a third use two methods to characterize their nanoparticles, but very few use more than two
methods. The methods most often used are dynamic light scattering, determination of zeta-potential,
Transmission Electron Microscopy and/or Scanning Electron Microscopy. Only about 18% report the
particle/agglomeration size distribution and materials concentration measured at different intervals
during the test.
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Figure 2. Number of ecotoxicity studies on copper oxide nanoparticles considering the reporting
and characterization parameters recommended in the Organisation for Economic Co-operation and
Development (OECD) guidance document [18].
6. Discussion
The BPR is revolutionary as it is the first piece of European legislation to implement the
Commission’s recommendation on a definition of nanom erials and to requir a separate dossier to
be submitted to European Chemical Agency (ECHA) with all data requirements for the NM used as an
active substance or present in biocidal products. However, being first-born is not always a privilege,
which certainly seems to be the case for the BPR and nanomaterials.
It is evident from our analysis of studies available in the open literature on the ecotoxicity
of CuO NPs, that the BPR requirements can only be partially met with regards to the specific
information requirements on ecotoxicological effects. There are only a few published studies
that the recommendations put forward in the OECD guidance document [18] into account. This
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may be due, in part, to lack of reporting on physical-chemical properties, e.g., pH and ionic
strength. Other shortcomings might be related technical difficulties in carrying out appropriate
and meaningful characterization of NPs. Therefore, nanotechnology-specific biocide test guidelines
should be developed.
6.1. Challenges for Manufacturers When Testing the Ecotoxicity of Nanomaterials
There are at least four major challenges that manufacturers are facing when attempting to perform
nano-specific ecotoxicological testing. The first major challenge relates to materials characterization.
Ideally, characterization should be done before, during and after the tests are completed and ideally,
the size of the primary NPs and size distribution should be reported along with the crystal structure,
surface chemistry, surface charge, solubility and the state of aggregation and agglomeration. It is,
however, scientifically and technically very challenging to determine all of these properties especially
for NMs that are non-spherical. This is further aggravated due to the tendency of some NPs to
aggregate and agglomerate in complex media such as synthetic or natural freshwater media.
Preparation of the NP suspensions by, e.g., sonication and use of solvents before the test is
performed have furthermore been observed affect the outcome of the subsequent ecotoxicological
testing. Several research projects, for instance Managing Risks of Nanomaterials (MARINA) and the
project called “NanoReg” funded by the European Framework Programme 7 [75], have attempted to
address this need, however, the most regulatory and/or environmentally relevant preparation method
for NP suspensions for ecotoxicity testing still has to be determined. Finally, the composition of the
media and the concentration of the NM used in the test as well as dynamic changes during incubation
have been reported in the scientific literature to affect the stability of NMs and their aggregation
and agglomeration. There is no easy way to deal with the four challenges ecotoxicological testing
of NMs but guidance from the OECD on how to address these challenges exist and more is under
way. It, however, seems clear that registrants of nanobiocides will have to be explorative in their
testing of nanomaterials for some time to come. The development of test guidelines has often taken
decades, but hopefully the urgent need, as emphasized by the BPR data requirements, can assist in
generating momentum to speed up the process of addressing the scientific and technical challenges of
ecotoxicological testing of NMs.
6.2. Challenges for Authorities with Regards to Approval of Active Substances under the BPR
There are challenges for the manufacturer or importer of a biocidal NM and there are challenges
for the competent authorities responsible for assessing the provided dossier. The BPR mandates
nano-specific test requirements and a specific nanobiocide risk assessment be performed by the
competent authorities.
These two requirements make implementing the BPR very ambitious and makes the BPR
a first mover when it comes to legislation of NMs. At this point in time there is no guidance
accompanying the BPR on how to provide nano-specific test results, or how to justify the scientific
appropriateness of the current test methods for the testing of NMs [16]. To date, no competent
authority has assessed a dossier, based on the nano-specific data requirements according to the
available assessment reports [76]; however, one biocidal NM product was approved prior to the
establishment of nano-specific testing requirements.
Synthetic Amorphous Silicon Dioxide (SAS) is currently the only NM approved as an active
substance under the BPR. The dossier submitted for the approval did not include nano-specific testing
for two reasons; firstly, as the dossier for approval was submitted and evaluated before September
2013, the evaluation was based on principles laid out in the Biocidal Product Directive (BPD), which
is the directive from 1998 that preceded the BPR, where no nano-specific provisions were included.
Secondly, because SAS according to the manufacturers will be present in stable aggregates of 1–6 µm
in the active substance, the exposure to primary particles in the nanoscale is not expected during the
intended use, and the risk of individual particles does therefore not need to be assessed according to
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the Assessment Report [77]. Before authorization of an active substance can be granted, an Assessment
Report has be prepared by a given Member State and reviewed by the Standing Committee on Biocidal
Products, whose opinion will subsequently serve as the basis for European Commission’s decision
on whether to approve the substance or not. As this is the first NM to be authorized, the procedure
followed in the case of SAS may be precedent for subsequent evaluations of nanobiocides under the
BPR. This could create a loophole for not needing to provide hazard data on individual particles, if
data showing that the particles form stable aggregates can be provided.
The process for authorization of an active ingredient requires that an Assessment Report be
prepared by a given Member State and reviewed by the Standing Committee on Biocidal Products,
whose opinion will subsequently serve as the basis for European Commission’s decision on whether
to approve the substance or not. Synthetic Amorphous Silicon Dioxide (SAS) is currently the only
NM approved as an active substance under the BPR, but was approved prior to September 2013 when
nano-specific testing requirements were laid out in the BPR. Secondly, because SAS will be present in
stable aggregates of 1–6 µm in the active substance, the exposure to primary particles in the nanoscale
is not expected during the intended use, and the risk of individual particles did not need to be assessed
according to the Assessment Report [77]. As this is the first NM to be authorized, the procedure
followed in the case of SAS may be precedent for subsequent evaluations of nanobiocides under the
BPR. That is, if data showing that the particles form stable aggregates can be provided then hazard
data on individual particles is not needed. According to Annex II of the BPR [4] justification of the
scientific appropriateness of the applied test methods for the testing of the NM should be provided [4].
This was not provided for SAS because it was evaluated according to the BPD prior to the existence of
nano-specific requirements in the BPR (1 September 2013). Dossiers submitted after 1 September 2013
should contain justification for all testing.
6.3. The Biocidal Product Regulation Will Provide Valuable Data
Although the inclusion of comprehensive nano-specific provisions in the BPR may cause many
challenges for both the manufacturers and the regulatory bodies, it will also help to advance the
knowledge on the use of nanobiocides on the market and related risks thereof. For instance,
the responses from the manufacturers/importers to the Commission inquiry regarding potential
nano-biocides, currently supported in the “existing” active substance Review Programme and
will provide valuable information on the number and types of nanobiocides that will be in the
marketplace in the future. Furthermore, once nanobiocides are approved, member states are required
to report information on the use of NMs in biocidal products and their potential risks every five
years starting 1 September 2015 [4]. This information will expand the knowledge of the use and
potential effects of nano-biocides in the future. The inclusion of the nano-specific provisions in the
BPR may also help accelerate the process of developing nano-specific test guidelines and adequate
characterization methods.
7. Conclusions
Due to the increase in potential use of NMs in biocidal products, nano-specific provisions were
implemented in the BPR to assist the development and approval of these products, while ensuring
adequate protection of consumers and the environment [14]. However, the lack of nano-specific
guidance could conceivably be an obstacle for manufacturers or importers, who wish to introduce
new nano-biocides into the market, as official information on establishment of appropriate data is
missing. On the other hand, the lack of official guidance may also result in placing of biocidal products
containing NMs on the market, where the hazard potential have not been sufficiently investigated,
resulting in inadequate protection of humans and/or the environment. Therefore, there is an urgent
need to incorporate guidance on nano-specific information requirements into the BPR to fulfill the
original purpose of the regulation regarding nano-biocides.
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